Skip to main content
Birgit Knoechel, MD, Pediatric Hematology & Oncology, Boston, MA, Boston Children's Hospital

BirgitKnoechelMD

Pediatric Hematology & Oncology Boston, MA

Clinical Fellow in Pediatrics, Boston Children's Hospital

Dr. Knoechel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Knoechel's full profile

Already have an account?

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2008 - 2012
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pediatrics, 2006 - 2008
  • Albert Ludwigs University Faculty of Medicine
    Albert Ludwigs University Faculty of MedicineClass of 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2025
  • MA State Medical License
    MA State Medical License 2010 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Chromatin Structure Dynamics Preserve Genome Stability in Multiple Myeloma
    Birgit Knoechel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Defining the Differentiation States of Multiple Myeloma at Single Cell Resolution Reveals Opportunities for Immunotherapy
    Birgit Knoechel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Circulating Tumor DNA in the Peripheral Blood As Early Predictor of Clinical Outcome in Relapsed/ Refractory Multiple Myeloma
    Birgit Knoechel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • The AACR Announces the Recipient of the AACR-the Mark Foundation NextGen Grant for Transformative Cancer Research
    The AACR Announces the Recipient of the AACR-the Mark Foundation NextGen Grant for Transformative Cancer ResearchJune 26th, 2018
  • Single Genetic Abnormality Accelerates, Removes the Brakes on Ewing Sarcoma Tumor Growth
    Single Genetic Abnormality Accelerates, Removes the Brakes on Ewing Sarcoma Tumor GrowthJanuary 16th, 2015

Hospital Affiliations